483
Andrew C. Siesennop, MDFDA 483 - Andrew C. Siesennop, MD - August 04, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Andrew C. Siesennop, MD in Boston, MA, revealed a significant issue with the conduct of an investigational study. The firm failed to follow its investigational plan, resulting in three subjects being incorrectly dosed with the study drug. This indicates a deviation from proper clinical trial procedures.
Open in Dashboard
ID · 507aefc9-8f3c-4b92-88d6-1fc83d8052e3